OpenNeedle Ask your own

Question explored with the scientific record

is there a solution for andromis alopecia in female

Nov 20, 2026 · 6 sources used · OpenNeedle synthesis
Yes, there are real treatments for female pattern hair loss, but "solution" overstates it. They slow loss and regrow some hair; none cures it.

Minoxidil is the best-supported option. In a 113-woman trial, once-daily 5% foam grew about as much hair as twice-daily 2% solution, with fewer side effects [2]. The catch is that minoxidil only works if your scalp converts it with an enzyme called sulfotransferase. A plucked-hair test of that enzyme predicted who responded with 93% sensitivity and 83% specificity [1], and a small study found 5 days of topical tretinoin converted 43% of predicted nonresponders into responders [4]. So a chunk of women are wasting money and months on minoxidil that was never going to work for them.

TreatmentWhat the evidence showsMain catch
Topical minoxidil 5% foam+31.9 hairs vs +28.4 for 2% solution at 24 weeks [2]Needs the enzyme; test predicts response [1]
Low-dose oral minoxidil79.7% improved, none worsened, in 148 women [6]Facial hair growth in 17% [6]
PRP injectionsHair count and diameter up in 4 studies [5]One placebo trial found no difference [5]
SpironolactoneUsed at 100-200 mg/day [3]No drug gives cosmetically acceptable growth for most [3]

A 1997 review was blunt: no drug has proven cosmetically acceptable hair growth for the majority of women, and long-term maintenance is unresolved [3]. That is the honest ceiling. The newer evidence adds options, not a cure. The PRP review is mixed, with one placebo-controlled study finding no difference [5]. The oral minoxidil data is mostly small and observational [6]. None of these records show a long-term safety trial, and none compare treated women to genuinely untreated women over years.

My call: minoxidil is worth trying first, ideally after a response test, and add spironolactone or PRP only with clear expectations. Confidence: moderate.

Keep digging

Sources used 6

  1. Sulfotransferase activity in plucked hair follicles predicts response to topical minoxidil in the treatment of female androgenetic alopecia Dermatologic Therapy (2014) Thin

    This study demonstrates that sulfotransferase activity in plucked hair follicles can predict the response to topical minoxidil in female patients with androgenetic alopecia, achieving 93% sensitivity and 83% specificity.

    DOI: 10.1111/dth.12130
  2. A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women Journal of the American Academy of Dermatology (2011) Thin

    This study compares the efficacy, safety, and acceptability of once-daily 5% minoxidil topical foam versus twice-daily 2% minoxidil topical solution in treating androgenetic alopecia in women, finding that the foam is noninferior and associated with fewer side effects.

    DOI: 10.1016/j.jaad.2010.09.724
  3. CLINICAL UPDATES IN HAIR Dermatologic Clinics (1997) Thin

    A comprehensive review of the biochemical mechanisms, clinical observations, and therapeutic options for male and female androgenetic alopecia, highlighting local scalp hormone metabolism (notably 5α-reductase and aromatase), androgen receptor signaling, and emerging treatments …

    DOI: 10.1016/S0733-8635(05)70413-7
  4. Tretinoin enhances minoxidil response in androgenetic alopecia patients by upregulating follicular sulfotransferase enzymes Dermatologic Therapy (2019) Thin

    A small prospective cohort study showing that 5 days of topical tretinoin increases follicular sulfotransferase activity and converts 43% of predicted minoxidil nonresponders to responders in androgenetic alopecia.

    DOI: 10.1111/dth.12915
  5. Investigating the Safety and Efficacy of Platelet-Rich Plasma (PRP) Treatment for Female Androgenetic Alopecia: Review of the Literature Medicina (2021) systematic review Strong

    This review of eight female-only studies found PRP improved hair count/diameter in most studies, high satisfaction/QoL, no serious adverse events; one single-session placebo-controlled study found no difference, and minoxidil outperformed PRP on objective hair measures.

    DOI: 10.3390/medicina57040311
  6. Review of oral minoxidil as treatment of hair disorders: in search of the perfect dose Journal of the European Academy of Dermatology and Venereology (2021) Thin

    This article reviews the emerging use of low-dose oral minoxidil for various hair disorders, summarizing dosing patterns, efficacy across conditions (AGA, female/male pattern hair loss, TE, AA, LPP, FFA, etc.), safety profiles, and the need for standardized outcome measures to g…

    DOI: 10.1111/jdv.17216

Your question next

What do you want to know?

No question is too uncomfortable for the evidence. Bring yours.

Ask your question →